ArticleHaematologica2025

Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma.

Julia Wendler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.